Arch Biopartners's total assets for Q1 2025 were C$533.53K, a decrease of -65.34% from the previous quarter. TSE:ARCH total liabilities were C$4.79M for the fiscal quarter, a -40.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.